BNP Paribas Asset Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
VCM
VPM
N
BNP Paribas Asset Management's PAHC Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Phibro Animal Health (PAHC) stake by 34% in Q1 2026, buying an estimated $6.95K and bringing the position to 579 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.
BNP Paribas Asset Management first reported a position in PAHC in Q2 2025 and has held it in 4 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- BNP Paribas Asset Management held 579 shares of Phibro Animal Health worth $32K as of Q1 2026.
- BNP Paribas Asset Management bought 146 Phibro Animal Health shares in Q1 2026, an estimated $6.95K.
- Phibro Animal Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1884 holding.
- BNP Paribas Asset Management first reported a position in Phibro Animal Health in Q2 2025 and has held it in 4 quarters since.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.